Deep phenotyping brings accuracy to precision medicine

Biotech companies are leveraging the wealth of omics and imaging data to study deep phenotypes for a range of clinical applications including precision medicine approaches to liver disease, neurodegenerative disorders and infertility.

Related Keywords

Luxembourg , United Kingdom , British , Mylene Yao , Jens Schwamborn , Vyant Bio , , Ochre Bio ,